Nothing Special   »   [go: up one dir, main page]

IN2015DN03931A - - Google Patents

Download PDF

Info

Publication number
IN2015DN03931A
IN2015DN03931A IN3931DEN2015A IN2015DN03931A IN 2015DN03931 A IN2015DN03931 A IN 2015DN03931A IN 3931DEN2015 A IN3931DEN2015 A IN 3931DEN2015A IN 2015DN03931 A IN2015DN03931 A IN 2015DN03931A
Authority
IN
India
Application number
Inventor
Chang Yi Wang
Original Assignee
United Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United Biomedical Inc filed Critical United Biomedical Inc
Publication of IN2015DN03931A publication Critical patent/IN2015DN03931A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/125Picornaviridae, e.g. calicivirus
    • A61K39/135Foot- and mouth-disease virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55516Proteins; Peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32111Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN3931DEN2015 2012-11-16 2015-05-08 IN2015DN03931A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2012/065386 WO2014077825A1 (en) 2012-11-16 2012-11-16 Synthetic peptide-based emergency vaccine against foot and mouth disease (fmd)

Publications (1)

Publication Number Publication Date
IN2015DN03931A true IN2015DN03931A (en) 2015-10-02

Family

ID=50731571

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3931DEN2015 IN2015DN03931A (en) 2012-11-16 2015-05-08

Country Status (12)

Country Link
US (1) US10420832B2 (en)
EP (2) EP3777886A1 (en)
JP (1) JP2016501850A (en)
CN (1) CN104244973B (en)
AU (2) AU2012394394A1 (en)
BR (1) BR112015010756B1 (en)
CA (1) CA2890678C (en)
HU (1) HUE051277T2 (en)
IN (1) IN2015DN03931A (en)
MX (1) MX2015006170A (en)
TW (1) TWI620574B (en)
WO (1) WO2014077825A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104162152A (en) * 2013-05-16 2014-11-26 申联生物医药(上海)有限公司 Swine foot and mouth disease O-type synthetic peptide vaccine and preparation method thereof
JP6586083B2 (en) 2013-09-19 2019-10-02 ゾエティス・サービシーズ・エルエルシー Oily adjuvant
CN107106674A (en) * 2015-01-16 2017-08-29 硕腾服务有限责任公司 Aftosa vaccine
CN104672312B (en) * 2015-03-20 2019-03-19 中牧实业股份有限公司 Ox foot-and-mouth disease a type polypeptide vaccine
CN105418738B (en) * 2015-07-03 2019-04-19 申联生物医药(上海)有限公司 Foot and mouth disease virus A type antigen polypeptide, fused antigen polypeptide and vaccine
BR112018009645A2 (en) * 2015-11-11 2018-11-13 Intrexon Corp compositions and methods for the expression of various biologically active polypeptides from a single vector for treatment of cardiac conditions and other conditions
KR20220064417A (en) 2016-06-02 2022-05-18 조에티스 서비시즈 엘엘씨 Vaccine against infectious bronchitis
CN106421776A (en) * 2016-08-31 2017-02-22 天津瑞普生物技术股份有限公司 T cell epitope synthetic peptide adjuvant capable of strengthening immune potency of foot-and-mouth disease subunit vaccine
US10172933B2 (en) 2016-10-31 2019-01-08 The United States Of America, As Represented By The Secretary Of Agriculture Mosaic vaccines for serotype a foot-and-mouth disease virus
JP7174492B2 (en) * 2017-01-04 2022-11-17 ウォルグ ファーマシューティカルズ (ハンジョウ) カンパニー,リミテッド S-arrestin peptides and their therapeutic use
CN106986925B (en) * 2017-05-08 2020-08-25 中牧实业股份有限公司 O-type and A-type bivalent synthetic peptide vaccine for bovine foot and mouth disease and preparation method and application thereof
CN107365367A (en) * 2017-08-16 2017-11-21 山东省农业科学院奶牛研究中心 A types FMDV VP1 Protein Epitopes gene polypeptide and its application
EP3909970A1 (en) * 2020-05-14 2021-11-17 Consejo Superior De Investigaciones Científicas Peptide vaccines for the prevention of foot-and-mouth disease
CN117304277B (en) * 2023-09-26 2024-03-08 中国农业科学院兰州兽医研究所 O-type foot-and-mouth disease virus VP4 protein T cell epitope polypeptide and application thereof
CN117304271B (en) * 2023-09-27 2024-04-16 中国农业科学院兰州兽医研究所 O-type foot-and-mouth disease virus VP2 protein T cell epitope polypeptide and application thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3382459D1 (en) 1982-04-14 1991-12-19 James L Bittle ARTIFICIAL PIKORNAVIRUSANTIGEN.
US4732971A (en) 1985-06-03 1988-03-22 Eli Lilly And Company Synthetic vaccines for foot and mouth disease
US5476765A (en) 1987-01-09 1995-12-19 United Biomedical, Inc. Synthetic peptide compositions with immunoreactivities to antibodies to HTLV and as vaccines
US5864008A (en) * 1988-03-25 1999-01-26 James; Stephen Peptides derived from foot-and-mouth disease virus, pharmaceutical compositions, and methods for using the peptides
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
GB8920357D0 (en) 1989-09-08 1989-10-25 Wellcome Found Peptides
US5106726A (en) 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
DE69332602T2 (en) * 1992-10-14 2003-11-13 Sagem S.A., Paris Telephone containing modem
WO1994025060A1 (en) 1993-04-27 1994-11-10 Ladd Anna E Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
US5759551A (en) 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
AU8091694A (en) 1993-10-26 1995-05-22 United Biomedical Inc. Structured synthetic antigen libraries as diagnostics, vaccines and therapeutics
FR2736642B1 (en) 1995-07-10 1997-09-12 Pasteur Institut IMMUNOVECTORS, IN PARTICULAR ANTIBODIES AND FRAGMENTS OF ANTIBODIES FOR USE IN THE INTRACELLULAR AND INTRANUCLEAR TRANSPORT OF BIOLOGICALLY ACTIVE PRINCIPLES IN PARTICULAR OF HAPTENES, PROTEINS AND NUCLEIC ACIDS
US6107021A (en) 1998-06-20 2000-08-22 United Biomedical, Inc. Synthetic peptide vaccines for foot-and-mouth disease
TWI229679B (en) 1998-06-20 2005-03-21 United Biomedical Inc Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens
US8088388B2 (en) 2002-02-14 2012-01-03 United Biomedical, Inc. Stabilized synthetic immunogen delivery system
EP2301972A1 (en) * 2002-08-12 2011-03-30 The Council Of The Queensland Institute Of Medical Research Method to prepare immunogenic lipopeptides comprising T-helper and B-cell epitopes
CN102168088B (en) * 2010-12-23 2012-12-26 中国农业科学院兰州兽医研究所 T cell immunogen gene TI and applications thereof in foot-and-mouth disease protein subunit vaccine and inactivated vaccine

Also Published As

Publication number Publication date
US20150306203A1 (en) 2015-10-29
AU2018232999B2 (en) 2020-02-27
AU2018232999A1 (en) 2018-10-11
TWI620574B (en) 2018-04-11
EP2919808B1 (en) 2020-07-29
US10420832B2 (en) 2019-09-24
AU2012394394A1 (en) 2015-06-04
JP2016501850A (en) 2016-01-21
TW201420114A (en) 2014-06-01
BR112015010756A8 (en) 2018-01-16
MX2015006170A (en) 2015-08-07
CN104244973B (en) 2017-10-20
EP2919808A4 (en) 2016-10-12
CA2890678A1 (en) 2014-05-22
WO2014077825A1 (en) 2014-05-22
HUE051277T2 (en) 2021-03-01
EP3777886A1 (en) 2021-02-17
CN104244973A (en) 2014-12-24
CA2890678C (en) 2022-02-22
BR112015010756A2 (en) 2017-08-22
EP2919808A1 (en) 2015-09-23
BR112015010756B1 (en) 2022-04-12

Similar Documents

Publication Publication Date Title
BR112014017635A2 (en)
BR112014019511A2 (en)
BR112014017614A2 (en)
BR112014017690A2 (en)
BR112014017625A2 (en)
BR112014017659A2 (en)
BR112014017646A2 (en)
BR112014017638A2 (en)
BR112014018003A2 (en)
BR112014017607A2 (en)
BR112014018936A2 (en)
BR112014017634A2 (en)
BR112014017609A2 (en)
BR112014024017A2 (en)
BR112014017644A2 (en)
IN2015DN03931A (en)
BR112014017647A2 (en)
BR112014013184A8 (en)
BR112014017618A2 (en)
BR112014019303A2 (en)
BR112014018915A2 (en)
BR112014017630A2 (en)
BR112014017652A2 (en)
BR112014017621A2 (en)
BR112014017622A2 (en)